Prediction of adverse pregnancy outcome by first-trimester maternal serum PAPP-A
Preeclampsia occurs in 2 to 5% of all pregnancies in developed countries. Together with IUGR it consists one of the leading reasons for perinatal death and childhood handicap. This is why many authors are looking for a widely usable and easy to perform test for evaluation of the patients at risk for preeclampsia an IUGR. PAPP-A is a protein complex produced by the developing trophoblast which is used as a marker for Downs' syndrome. Previous studies have shown an association between low first trimester maternal serum PAPP-A and subsequent development of pregnancy complications.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Akusherstvo i ginekologiia - 49(2010), 1 vom: 19., Seite 40-3 |
| Sprache: |
Bulgarisch |
|---|
| Beteiligte Personen: |
Stoikova, V [VerfasserIn] |
|---|
| Themen: |
EC 3.4.24.- |
|---|
| Anmerkungen: |
Date Completed 05.10.2010 Date Revised 19.11.2015 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM200544802 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM200544802 | ||
| 003 | DE-627 | ||
| 005 | 20231223220755.0 | ||
| 007 | tu | ||
| 008 | 231223s2010 xx ||||| 00| ||bul c | ||
| 028 | 5 | 2 | |a pubmed24n0668.xml |
| 035 | |a (DE-627)NLM200544802 | ||
| 035 | |a (NLM)20734665 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a bul | ||
| 100 | 1 | |a Stoikova, V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prediction of adverse pregnancy outcome by first-trimester maternal serum PAPP-A |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 05.10.2010 | ||
| 500 | |a Date Revised 19.11.2015 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Preeclampsia occurs in 2 to 5% of all pregnancies in developed countries. Together with IUGR it consists one of the leading reasons for perinatal death and childhood handicap. This is why many authors are looking for a widely usable and easy to perform test for evaluation of the patients at risk for preeclampsia an IUGR. PAPP-A is a protein complex produced by the developing trophoblast which is used as a marker for Downs' syndrome. Previous studies have shown an association between low first trimester maternal serum PAPP-A and subsequent development of pregnancy complications | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Pregnancy-Associated Plasma Protein-A |2 NLM | |
| 650 | 7 | |a EC 3.4.24.- |2 NLM | |
| 700 | 1 | |a Ivanov, St |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Akusherstvo i ginekologiia |d 1962 |g 49(2010), 1 vom: 19., Seite 40-3 |w (DE-627)NLM000046221 |x 0324-0959 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2010 |g number:1 |g day:19 |g pages:40-3 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2010 |e 1 |b 19 |h 40-3 | ||